Center for Translational Research in Hematological Malignancies

Medicine & Life Sciences

1. Multiple Myeloma 100%
2. T-Lymphocytes 55%
3. Dendritic Cells 36%
4. Immunotherapy 36%
5. Neoplasms 31%
6. Mantle-Cell Lymphoma 27%
7. Myasthenia Gravis 27%
8. Immunity 17%
9. Interleukin-9 17%
10. Apoptosis 16%
11. B-Lymphocytes 16%
12. Bortezomib 15%
13. dectin 1 14%
14. In Vitro Techniques 12%
15. Osteoclasts 12%
16. Cholinergic Receptors 12%
17. p38 Mitogen-Activated Protein Kinases 12%
18. Macrophages 11%
19. Neoplasm Antigens 11%
20. Vaccines 11%
21. Growth 10%
22. Interleukin-33 10%
23. Monoclonal Gammopathy of Undetermined Significance 10%
24. Paraproteinemias 10%
25. Monoclonal Antibodies 10%
26. Cytotoxic T-Lymphocytes 9%
27. Lenalidomide 9%
28. Myeloma Proteins 9%
29. Bone Marrow 8%
30. Antibodies 8%
31. Interleukin-2 8%
32. Helper-Inducer T-Lymphocytes 8%
33. Therapeutics 8%
34. Interferons 8%
35. Blood Cells 8%
36. Peptides 8%
37. Major Histocompatibility Complex 8%
38. Monocytes 7%
39. Cell Survival 7%
40. Proteasome Inhibitors 7%
41. Hepatocellular Carcinoma 7%
42. Interleukin-6 7%
43. T-Lymphocyte Subsets 7%
44. carfilzomib 7%
45. Cytokines 7%
46. HLA-A*02:01 antigen 7%
47. Drug Therapy 7%
48. Proteins 7%
49. Immune System 6%
50. azaspirane 6%
51. Cell Proliferation 6%
52. Tumor Microenvironment 6%
53. Therapeutic Uses 6%
54. Cell Line 6%
55. Vaccination 6%
56. Chimeric Antigen Receptors 6%
57. Osteogenesis 5%
58. Heterografts 5%
59. Granulocyte-Macrophage Colony-Stimulating Factor 5%
60. Cell Differentiation 5%
61. Activated-Leukocyte Cell Adhesion Molecule 5%
62. Antigens 5%
63. Genes 5%
64. Immunoglobulin G 5%
65. Antigen-Presenting Cells 5%
66. 2-5A-dependent ribonuclease 5%
67. Th1 Cells 5%